Investment In Telemedicine Requires Reimbursement Incentive - HP Exec
This article was originally published in The Gray Sheet
Executive Summary
R&D funding by device manufacturers in the field of telemedicine likely would increase if the Health Care Financing Administration provided a reasonable assurance that a broader array of telehealth procedures would be reimbursed under Medicare, suggested Albert Kyle, group manager, new clinical ventures, Hewlett-Packard Medical Products Group.